The global Electronic Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Electronic Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Electronic Drug Delivery Systems.
Report Scope
The Electronic Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Electronic Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Electronic Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Group
Medtronic
United Therapeutics Corporation
Insulet Corporation
Bayer
Novo Nordisk
Companion Medical
Tandem Diabetes Care Inc
Roche Holding AG
Amgen
AstraZeneca
Findair
Vicentra
Cane' SpA
Debiotech
Segment by Type
Electronic Wearable Infusion Pumps
Electronic Autoinjectors
Electronic Injection Pens
Electronic Inhalers
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Electronic Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Electronic Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Electronic Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Electronic Drug Delivery Systems
1.2 Electronic Drug Delivery Systems Segment by Type
1.2.1 Global Electronic Drug Delivery Systems Market Value Comparison by Type (2024-2030)
1.2.2 Electronic Wearable Infusion Pumps
1.2.3 Electronic Autoinjectors
1.2.4 Electronic Injection Pens
1.2.5 Electronic Inhalers
1.3 Electronic Drug Delivery Systems Segment by Application
1.3.1 Global Electronic Drug Delivery Systems Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Electronic Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Electronic Drug Delivery Systems Revenue 2019-2030
1.4.2 Global Electronic Drug Delivery Systems Sales 2019-2030
1.4.3 Global Electronic Drug Delivery Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Electronic Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Electronic Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Electronic Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Electronic Drug Delivery Systems Average Price by Manufacturers (2019-2024)
2.4 Global Electronic Drug Delivery Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Electronic Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Electronic Drug Delivery Systems, Product Type & Application
2.7 Electronic Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Electronic Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Electronic Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Electronic Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Electronic Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Electronic Drug Delivery Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Electronic Drug Delivery Systems Global Electronic Drug Delivery Systems Sales by Region: 2019-2030
3.2.1 Global Electronic Drug Delivery Systems Sales by Region: 2019-2024
3.2.2 Global Electronic Drug Delivery Systems Sales by Region: 2025-2030
3.3 Global Electronic Drug Delivery Systems Global Electronic Drug Delivery Systems Revenue by Region: 2019-2030
3.3.1 Global Electronic Drug Delivery Systems Revenue by Region: 2019-2024
3.3.2 Global Electronic Drug Delivery Systems Revenue by Region: 2025-2030
3.4 North America Electronic Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Electronic Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Electronic Drug Delivery Systems Sales by Country (2019-2030)
3.4.3 North America Electronic Drug Delivery Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Electronic Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Electronic Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Electronic Drug Delivery Systems Sales by Country (2019-2030)
3.5.3 Europe Electronic Drug Delivery Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Electronic Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Electronic Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Electronic Drug Delivery Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Electronic Drug Delivery Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Electronic Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Electronic Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Electronic Drug Delivery Systems Sales by Country (2019-2030)
3.7.3 Latin America Electronic Drug Delivery Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Electronic Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Electronic Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Electronic Drug Delivery Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Electronic Drug Delivery Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Electronic Drug Delivery Systems Sales by Type (2019-2030)
4.1.1 Global Electronic Drug Delivery Systems Sales by Type (2019-2024)
4.1.2 Global Electronic Drug Delivery Systems Sales by Type (2025-2030)
4.1.3 Global Electronic Drug Delivery Systems Sales Market Share by Type (2019-2030)
4.2 Global Electronic Drug Delivery Systems Revenue by Type (2019-2030)
4.2.1 Global Electronic Drug Delivery Systems Revenue by Type (2019-2024)
4.2.2 Global Electronic Drug Delivery Systems Revenue by Type (2025-2030)
4.2.3 Global Electronic Drug Delivery Systems Revenue Market Share by Type (2019-2030)
4.3 Global Electronic Drug Delivery Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Electronic Drug Delivery Systems Sales by Application (2019-2030)
5.1.1 Global Electronic Drug Delivery Systems Sales by Application (2019-2024)
5.1.2 Global Electronic Drug Delivery Systems Sales by Application (2025-2030)
5.1.3 Global Electronic Drug Delivery Systems Sales Market Share by Application (2019-2030)
5.2 Global Electronic Drug Delivery Systems Revenue by Application (2019-2030)
5.2.1 Global Electronic Drug Delivery Systems Revenue by Application (2019-2024)
5.2.2 Global Electronic Drug Delivery Systems Revenue by Application (2025-2030)
5.2.3 Global Electronic Drug Delivery Systems Revenue Market Share by Application (2019-2030)
5.3 Global Electronic Drug Delivery Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Group
6.1.1 Merck Group Corporation Information
6.1.2 Merck Group Description and Business Overview
6.1.3 Merck Group Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Group Electronic Drug Delivery Systems Product Portfolio
6.1.5 Merck Group Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Electronic Drug Delivery Systems Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 United Therapeutics Corporation
6.3.1 United Therapeutics Corporation Corporation Information
6.3.2 United Therapeutics Corporation Description and Business Overview
6.3.3 United Therapeutics Corporation Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 United Therapeutics Corporation Electronic Drug Delivery Systems Product Portfolio
6.3.5 United Therapeutics Corporation Recent Developments/Updates
6.4 Insulet Corporation
6.4.1 Insulet Corporation Corporation Information
6.4.2 Insulet Corporation Description and Business Overview
6.4.3 Insulet Corporation Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Insulet Corporation Electronic Drug Delivery Systems Product Portfolio
6.4.5 Insulet Corporation Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Electronic Drug Delivery Systems Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novo Nordisk Electronic Drug Delivery Systems Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Companion Medical
6.6.1 Companion Medical Corporation Information
6.6.2 Companion Medical Description and Business Overview
6.6.3 Companion Medical Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Companion Medical Electronic Drug Delivery Systems Product Portfolio
6.7.5 Companion Medical Recent Developments/Updates
6.8 Tandem Diabetes Care Inc
6.8.1 Tandem Diabetes Care Inc Corporation Information
6.8.2 Tandem Diabetes Care Inc Description and Business Overview
6.8.3 Tandem Diabetes Care Inc Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tandem Diabetes Care Inc Electronic Drug Delivery Systems Product Portfolio
6.8.5 Tandem Diabetes Care Inc Recent Developments/Updates
6.9 Roche Holding AG
6.9.1 Roche Holding AG Corporation Information
6.9.2 Roche Holding AG Description and Business Overview
6.9.3 Roche Holding AG Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Holding AG Electronic Drug Delivery Systems Product Portfolio
6.9.5 Roche Holding AG Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Amgen Electronic Drug Delivery Systems Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Electronic Drug Delivery Systems Description and Business Overview
6.11.3 AstraZeneca Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AstraZeneca Electronic Drug Delivery Systems Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Findair
6.12.1 Findair Corporation Information
6.12.2 Findair Electronic Drug Delivery Systems Description and Business Overview
6.12.3 Findair Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Findair Electronic Drug Delivery Systems Product Portfolio
6.12.5 Findair Recent Developments/Updates
6.13 Vicentra
6.13.1 Vicentra Corporation Information
6.13.2 Vicentra Electronic Drug Delivery Systems Description and Business Overview
6.13.3 Vicentra Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Vicentra Electronic Drug Delivery Systems Product Portfolio
6.13.5 Vicentra Recent Developments/Updates
6.14 Cane' SpA
6.14.1 Cane' SpA Corporation Information
6.14.2 Cane' SpA Electronic Drug Delivery Systems Description and Business Overview
6.14.3 Cane' SpA Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cane' SpA Electronic Drug Delivery Systems Product Portfolio
6.14.5 Cane' SpA Recent Developments/Updates
6.15 Debiotech
6.15.1 Debiotech Corporation Information
6.15.2 Debiotech Electronic Drug Delivery Systems Description and Business Overview
6.15.3 Debiotech Electronic Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Debiotech Electronic Drug Delivery Systems Product Portfolio
6.15.5 Debiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Electronic Drug Delivery Systems Industry Chain Analysis
7.2 Electronic Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Electronic Drug Delivery Systems Production Mode & Process
7.4 Electronic Drug Delivery Systems Sales and Marketing
7.4.1 Electronic Drug Delivery Systems Sales Channels
7.4.2 Electronic Drug Delivery Systems Distributors
7.5 Electronic Drug Delivery Systems Customers
8 Electronic Drug Delivery Systems Market Dynamics
8.1 Electronic Drug Delivery Systems Industry Trends
8.2 Electronic Drug Delivery Systems Market Drivers
8.3 Electronic Drug Delivery Systems Market Challenges
8.4 Electronic Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck Group
Medtronic
United Therapeutics Corporation
Insulet Corporation
Bayer
Novo Nordisk
Companion Medical
Tandem Diabetes Care Inc
Roche Holding AG
Amgen
AstraZeneca
Findair
Vicentra
Cane' SpA
Debiotech
听
听
*If Applicable.
